REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer’s disease, and Parkinson’s disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Reviva Pharmaceuticals Holdings, Inc.
OTC:RVPHHealthcare · Biotechnology
-5.00%$0.4256
Mkt Cap$5.58M
Float12.04M
O/S13.11M
Inst Own0.1%
SI3.3%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$19.86M
Total Assets$15.92M
Free Cash Flow-$24.59M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$407K
Total Equity$8.65M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:20
Nasdaq bars a compliance period at 1:250
- 1:20Reverse splitMar 9, 202620 shares → 1
Balance Sheet Details
Assets$15.92M
Liabilities$7.28M
Accounts Receivable$0
Accounts Payable$3.01M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2020-02-29 | 2019-02-28 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $725K | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | -$725K | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $11.71M | $22.91M | $31.42M | $18.95M | $4.85M | $295K | $196K | $946K |
| Selling, General, and Administrative | $8.49M | $7.89M | $8.08M | $5.36M | $5.25M | $2.14M | $181K | $176K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$0 |
| Total Operating Expenses | $20.2M | $30.8M | $39.5M | $24.31M | $10.1M | $2.43M | $377K | $1.12M |
| Operating Income (EBIT) | -$20.2M | -$30.8M | -$39.5M | -$24.31M | -$10.1M | -$2.43M | -$377K | -$1.12M |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $13K | $18K | $34K | $183K | $2K | $1.45M | $469K | $558K |
| Interest Income | $311K | $361K | $398K | $183K | $0 | $105K | $201 | $0 |
| Other Income (Expense) | $354K | $900K | $260K | -$12K | $1.59M | -$1.35M | -$469K | -$558K |
| Income Before Tax (EBT) | -$19.85M | -$29.9M | -$39.24M | -$24.32M | -$8.52M | -$3.78M | -$846K | -$1.68M |
| Income Tax Expense | $19K | $20K | $17K | $21K | $6K | $800 | $800 | $800 |
| Net Income | -$19.86M | -$29.92M | -$39.26M | -$24.34M | -$8.52M | -$3.78M | -$847K | -$1.68M |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -5.48 | -18.00 | -33.00 | -29.00 | -11.60 | -24.80 | -6.20 | -16.48 |
| Diluted EPS | -5.48 | -18.00 | -33.00 | -29.00 | -11.60 | -24.80 | -6.20 | -16.48 |
| Weighted Average OS | 3.63M | 1.66M | 1.19M | 975,824 | 739,542 | 153,084 | 138,531 | 101,984 |
| EBITDA | -$19.83M | $918K | $260K | $3.92M | -$10.1M | -$2.43M | -$376K | -$1.1M |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2020-02-29 | 2019-02-28 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $14.44M | $13.48M | $23.37M | $18.52M | $29.69M | $8.76M | $193 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $65.24M |
| Cash and Short-Term Investments | $14.44M | $13.48M | $23.37M | $18.52M | $29.69M | $8.76M | $193 | $65.24M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $665K | $666K | $333K | $404K | $1.72M | -$2K | $0 | $0 |
| Total Current Assets | $15.1M | $14.68M | $23.7M | $18.92M | $31.4M | $8.76M | $193 | $65.24M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $591 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $820K | $820K | $0 | $403.82M | $1.72M | $2K | $2K | $0 |
| Total Long-Term Assets | $820K | $820K | $0 | $403.82M | $1.72M | $2K | $2K | $0 |
| Other Assets | $0 | $0 | $0 | -$403.82M | -$1.72M | $0 | $0 | $0 |
| Total Assets | $15.92M | $15.5M | $23.7M | $18.92M | $31.4M | $8.76M | $3K | $65.24M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $3.01M | $6.28M | $3.85M | $3.52M | $510K | $1.01M | $225K | $0 |
| Short-Term Debt | $407K | $458K | $0 | $0 | $0 | $0 | $3.77M | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $2.72M | $0 |
| Other Current Liabilities | $486K | $636K | $400K | $299K | $1.84M | $0 | -$7K | $0 |
| Total Current Liabilities | $7.28M | $14.6M | $17.18M | $9.96M | $2.34M | $1.33M | $100K | $0 |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $89K | $807K | $567K | $373K | $1.96M | $2K | $0 |
| Total Long-Term Liabilities | $0 | $89K | $807K | $567K | $373K | $1.96M | $2K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $7.28M | $14.69M | $17.98M | $10.53M | $2.72M | $3.3M | $6.81M | $6.09M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $29.07M | $0 |
| Common Stock | $12K | $5K | $3K | $2K | $1K | $923 | $618 | $0 |
| Retained Earnings | -$184.14M | -$164.27M | -$134.35M | -$95.09M | -$66.83M | -$58.31M | -$54.53M | $0 |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | -$54.53M | $0 |
| Other Stockholders' Equity | $192.77M | $165.08M | $140.07M | $103.49M | $95.52M | $63.77M | $47.71M | - |
| Total Equity | $8.65M | $813K | $5.72M | $8.39M | $28.69M | $5.47M | -$6.81M | $0 |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $15.92M | $15.5M | $23.7M | $18.92M | $31.4M | $8.76M | $3K | $6.09M |
| Supplementary Data | ||||||||
| Total Debt | $407K | $458K | $0 | $0 | $0 | $0 | $3.77M | $0 |
| Net Debt | -$14.03M | -$13.02M | -$23.37M | -$18.52M | -$29.69M | -$8.76M | $4K | $0 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2020-02-29 | 2019-02-28 |
| Operating Activities | ||||||||
| Net Income | -$19.86M | -$29.92M | -$39.26M | -$24.34M | -$8.52M | -$3.78M | -$847K | -$1.68M |
| Depreciation & Amortization | $0 | $30.8M | $39.5M | $28.23M | $591 | $591 | $645 | $18K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $2.23M | $1.63M | $3.41M | $177K | $107K | $0 | $0 | $21K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$3.41M | $2.29M | $329K | $3.01M | -$498K | $775K | $158K | $0 |
| Other Working Capital | -$3.46M | -$6.83M | $6.96M | $5.92M | -$204K | -$3.1M | $476K | $542K |
| Total Working Capital Change | -$6.87M | -$4.54M | $7.28M | $8.93M | -$702K | -$2.33M | $634K | $542K |
| Other Non-Cash Items | -$89K | -$31.52M | -$39.26M | -$31.96M | -$1.55M | $2.05M | -$6K | $28K |
| Net Cash from Operating | -$24.59M | -$33.54M | -$28.32M | -$18.96M | -$10.67M | -$4.07M | -$218K | -$1.07M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | -$3.11M | - | - |
| Common Stock Issuance | $25.61M | $23.19M | $27.49M | $7.77M | $31.5M | $341K | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $5.68M | $19K | $98K | $9.38M | $100K | $175K |
| Net Cash from Financing | $25.56M | $23.65M | $33.17M | $7.79M | $31.6M | $12.83M | $100K | $175K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $962K | -$9.89M | $4.85M | -$11.17M | $20.93M | $8.76M | -$118K | $119K |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$24.59M | -$33.54M | -$28.32M | -$18.96M | -$10.67M | -$4.07M | -$218K | -$1.07M |
| Capital Expenditure | $0 | -$4 | $3 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$24.59M | -$33.54M | -$28.32M | -$18.96M | -$10.67M | -$4.07M | -$218K | -$1.07M |
| Cash at Beginning | $13.48M | $23.37M | $18.52M | $29.69M | $8.76M | $193 | $119K | $0 |
| Cash at End | $14.44M | $13.48M | $23.37M | $18.52M | $29.69M | $8.76M | $193 | $119K |